FR2321281A1 - 2,6-anthraquinonyleneamidines et leur utilisation therapeutique comme agents anti-amibiens - Google Patents

2,6-anthraquinonyleneamidines et leur utilisation therapeutique comme agents anti-amibiens

Info

Publication number
FR2321281A1
FR2321281A1 FR7625243A FR7625243A FR2321281A1 FR 2321281 A1 FR2321281 A1 FR 2321281A1 FR 7625243 A FR7625243 A FR 7625243A FR 7625243 A FR7625243 A FR 7625243A FR 2321281 A1 FR2321281 A1 FR 2321281A1
Authority
FR
France
Prior art keywords
anthraquinonyleneamidines
amibians
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7625243A
Other languages
English (en)
French (fr)
Other versions
FR2321281B1 (el
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FR2321281A1 publication Critical patent/FR2321281A1/fr
Application granted granted Critical
Publication of FR2321281B1 publication Critical patent/FR2321281B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195Radicals derived from nitrogen analogues of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7625243A 1975-08-22 1976-08-19 2,6-anthraquinonyleneamidines et leur utilisation therapeutique comme agents anti-amibiens Granted FR2321281A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60680575A 1975-08-22 1975-08-22

Publications (2)

Publication Number Publication Date
FR2321281A1 true FR2321281A1 (fr) 1977-03-18
FR2321281B1 FR2321281B1 (el) 1979-07-27

Family

ID=24429543

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7625243A Granted FR2321281A1 (fr) 1975-08-22 1976-08-19 2,6-anthraquinonyleneamidines et leur utilisation therapeutique comme agents anti-amibiens

Country Status (21)

Country Link
JP (1) JPS5225763A (el)
AR (1) AR213625A1 (el)
AU (1) AU508586B2 (el)
BE (1) BE845369A (el)
CA (1) CA1098127A (el)
CS (1) CS212773B2 (el)
DE (1) DE2637544A1 (el)
EG (1) EG12401A (el)
ES (1) ES450859A1 (el)
FR (1) FR2321281A1 (el)
GB (1) GB1553600A (el)
GR (1) GR60420B (el)
HU (1) HU173298B (el)
LU (1) LU75636A1 (el)
NL (1) NL7609230A (el)
NZ (1) NZ181596A (el)
PH (1) PH13216A (el)
PL (1) PL191945A1 (el)
PT (1) PT65506B (el)
SU (1) SU883002A1 (el)
ZA (1) ZA764516B (el)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154489B (de) * 1961-05-05 1963-09-19 Basf Ag Verfahren zur Trennung von Mono- und Diaminoanthrachinonen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154489B (de) * 1961-05-05 1963-09-19 Basf Ag Verfahren zur Trennung von Mono- und Diaminoanthrachinonen

Also Published As

Publication number Publication date
AR213625A1 (es) 1979-02-28
GR60420B (en) 1978-05-25
PL191945A1 (pl) 1978-12-04
PH13216A (en) 1980-02-07
NZ181596A (en) 1978-12-18
GB1553600A (en) 1979-09-26
PT65506B (en) 1978-02-15
JPS5225763A (en) 1977-02-25
HU173298B (hu) 1979-04-28
AU508586B2 (en) 1980-03-27
CS212773B2 (en) 1982-03-26
FR2321281B1 (el) 1979-07-27
EG12401A (en) 1980-03-31
BE845369A (fr) 1977-02-21
NL7609230A (nl) 1977-02-24
PT65506A (en) 1976-09-01
ZA764516B (en) 1977-07-27
SU883002A1 (ru) 1981-11-23
CA1098127A (en) 1981-03-24
DE2637544A1 (de) 1977-03-03
AU1669376A (en) 1978-02-16
LU75636A1 (el) 1977-03-29
ES450859A1 (es) 1978-04-01

Similar Documents

Publication Publication Date Title
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE839615A (fr) Nouvelles amidinourees, leur preparation et leur emploi
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
BE872886A (fr) Steroides, leur preparation et leur utilisation therapeutique
BE841537A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
FR2325635A1 (fr) N-alkyldiphenylamines et leur utilisation comme rodonticides
BE843152A (fr) Nouvelles cephalosporimes, leur preparation et leur emploi
BE838799A (fr) Polyesteramides insatures, leur preparation et leur utilisation
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
FR2323388A1 (fr) Nouveaux phenylpiperazinotetrahydronaphtols, leur preparation et leur utilisation therapeutique comme hypotenseurs
BE872990A (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE841536A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
BE825039A (fr) Leuco-colorants d'indolyl-methylene, leur preparation et leur utilisation
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
BE838233A (fr) Phenyl- et penzylphosphonate esters, leur preparation et leur utilisation
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE876680A (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
FR2315275A1 (fr) 1-acyl-1,2,3,4-tetrahydro-6-quinoleinols et leur preparation
LU80161A1 (fr) 2,1-benzisothiazoles,leur preparation et leur utilisation therapeutique
BE837646A (fr) Complexes asymetriques chromo-azomethine-1:2, leur preparation et leur utilisation comme colorants

Legal Events

Date Code Title Description
ST Notification of lapse